|
2021
|
Invention
|
5'-cap compounds and their uses in stabilizing rna, expressing proteins and in therapy.
The pres... |
|
|
Invention
|
Rna particles comprising polysarcosine. The present disclosure relates to RNA particles for deliv... |
|
2020
|
Invention
|
Il2 agonists. The invention relates to variants of interleukin-2 (IL2). In particular, the invent... |
|
|
Invention
|
Therapeutic rna for ovarian cancer. Disclosed herein are compositions, uses, and methods for trea... |
|
|
Invention
|
Treatment involving interleukin-2 (il2) and interferon (ifn). The present disclosure relates to m... |
|
|
Invention
|
Preparation and storage of liposomal rna formulations suitable for therapy. The present disclosur... |
|
|
Invention
|
Therapeutic rna for prostate cancer. Disclosed herein are compositions, uses, and methods for tre... |
|
|
Invention
|
Composite rna particles. The present disclosure relates to RNA particles for delivery of RNA to t... |
|
|
Invention
|
Localized administration of rna molecules for therapy. The present invention relates to local del... |
|
2019
|
Invention
|
Treatment involving therapeutic antibody and interleukin-2 (il2). Tumor cells often evade an immu... |
|
|
Invention
|
Therapeutic rna for solid tumor cancers. This disclosure relates to the field of therapeutic RNAs... |
|
|
Invention
|
Individualized vaccines for cancer. The present invention is in the field of tumor immunotherapy.... |
|
|
Invention
|
Il2 agonists. The invention relates to variants of interleukin-2 (IL2). In one embodiment, the IL... |
|
|
Invention
|
Method for determining at least one parameter of a sample composition comprising nucleic acid, su... |
|
|
Invention
|
Rna formulations suitable for therapy. The present invention relates to compositions comprising R... |
|
|
Invention
|
5'-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing rna, expre... |
|
|
Invention
|
5'-cap-trinucleotide- or higher oligonucleotide compounds and their uses in stabilizing rna, expr... |
|
|
Invention
|
Treatment using cytokine encoding rna. The present disclosure relates to methods and compositions... |
|
|
Invention
|
Formulation for administration of rna. The present invention relates to compositions comprising p... |
|
2018
|
Invention
|
Rna replicon for reprogramming somatic cells. The present invention embraces a RNA replicon that ... |
|
|
Invention
|
Method of enhancing rna expression in a cell. The present invention describes a virus-derived fac... |
|
|
Invention
|
Rna for treatment of autoimmune diseases. The present invention relates to non-immunogenic RNA. T... |
|
|
Invention
|
Methods and compositions for stimulating immune response. The present invention relates to method... |
|
|
G/S
|
Pharmaceuticals and veterinary preparations comprised of nucleic acids for medical purposes, spec... |
|
2017
|
Invention
|
Mhc-independent tumor-associated antigens. The present invention relates to novel tumor-associate... |
|
|
Invention
|
Dose determination for immunotherapeutic agents.
The present invention relates to methods for de... |
|
|
Invention
|
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy. The present... |
|
|
Invention
|
Methods for characterizing loss of antigen presentation. This invention relates to methods for sc... |
|
|
Invention
|
Methods for predicting the usefulness of disease specific amino acid modifications for immunother... |
|
|
Invention
|
Methods for providing single-stranded rna. The present invention relates to methods for providing... |
|
2016
|
Invention
|
Dose determination for immunotherapeutic agents. The present invention relates to methods for det... |
|
|
Invention
|
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy. The pre... |
|
|
Invention
|
Trans-replicating rna. The present invention generally relates to systems and methods suitable fo... |
|
|
Invention
|
Rna replicon for versatile and efficient gene expression. The present invention embraces a RNA re... |
